333 results
·
43ms
·
Sources: EU EUDAMED, US FDA
Filters
FDA Classification
×
Antigen, Invasive Fungal Pathogens
FDA classification
FDA Class 2
·Antigen, Invasive Fungal Pathogens
Medication Management System, Remote
FDA classification
FDA Class 2
·Medication Management System, Remote
System, Microarray-Based, Genome-Wide, Postnatal Chromosomal Abnormality Detection
FDA classification
FDA Class 2
·System, Microarray-Based, Genome-Wide, Postnatal Chromosomal Abnormality Detection
Kit, Conception-Assist, Home Use
FDA classification
FDA Class 2
·Kit, Conception-Assist, Home Use
Opioid Use Disorder Genetic Risk Variant Detection System And Collection Kit
FDA classification
FDA Class 3
·Opioid Use Disorder Genetic Risk Variant Detection System And Collection Kit
Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents
FDA classification
FDA Class 2
·Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents
Digital Cervical Cytology Slide Imaging System With Artificial Intelligence Algorithm
FDA classification
FDA Class 2
·Digital Cervical Cytology Slide Imaging System With Artificial Intelligence Algorithm
Cancer Predisposition Risk Assessment System
FDA classification
FDA Class 2
·Cancer Predisposition Risk Assessment System
Respiratory Virus Panel Nucleic Acid Assay System
FDA classification
FDA Class 2
·Respiratory Virus Panel Nucleic Acid Assay System
Immunohistochemistry Antibody Assay, C-Kit
FDA classification
FDA Class 3
·Immunohistochemistry Antibody Assay, C-Kit
Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings
FDA classification
FDA Class 2
·Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings
Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings
FDA classification
FDA Class 2
·Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings
System, Test, Radioallergosorbent (Rast) Immunological, Exempt Allergens
FDA classification
FDA Class 2
·System, Test, Radioallergosorbent (Rast) Immunological, Exempt Allergens